Maurizio Martini Selected Research

Maurizio Martini Research Topics

Disease

65	Neoplasms (Cancer) 06/2022 - 12/2002
23	Glioblastoma (Glioblastoma Multiforme) 04/2022 - 12/2008
9	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 12/2011
6	Prostatic Neoplasms (Prostate Cancer) 12/2022 - 02/2011
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 01/2002
6	Sarcoma (Soft Tissue Sarcoma) 01/2019 - 06/2013
6	Papillary Thyroid Cancer 01/2019 - 06/2013
5	Carcinoma (Carcinomatosis) 01/2022 - 03/2012
5	Neoplasm Metastasis (Metastasis) 12/2021 - 03/2015
5	Glioma (Gliomas) 01/2021 - 12/2011
5	Hodgkin Disease (Hodgkin's Disease) 01/2018 - 03/2008
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2013 - 03/2007
4	Squamous Cell Carcinoma of Head and Neck 02/2022 - 01/2021
4	Adenocarcinoma 01/2021 - 05/2017
4	Disease Progression 01/2021 - 12/2008
3	Ependymoma 02/2021 - 11/2017
3	Carcinogenesis 01/2021 - 01/2017
3	Inflammation (Inflammations) 01/2021 - 11/2007
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 02/2016
3	Non-alcoholic Fatty Liver Disease 01/2021 - 02/2018
3	Hemorrhage 11/2020 - 01/2013
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2019 - 07/2004
3	Thrombocytosis (Thrombocythemia) 03/2012 - 10/2002
3	Polycythemia (Erythrocytosis) 03/2012 - 10/2002
3	Lymphoma (Lymphomas) 07/2009 - 03/2007
3	Essential Thrombocythemia 10/2008 - 10/2002
3	Polycythemia Vera 10/2008 - 10/2002
2	Thyroid Neoplasms (Thyroid Cancer) 06/2022 - 05/2017
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 02/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 06/2016
2	Hypoxia (Hypoxemia) 05/2020 - 07/2008
2	Brain Neoplasms (Brain Tumor) 01/2018 - 01/2017
2	Hyperplasia 05/2017 - 02/2011
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016 - 08/2008
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2014 - 09/2006
2	Infections 03/2013 - 02/2013
2	Acquired Immunodeficiency Syndrome (AIDS) 03/2007 - 01/2002
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Non-Muscle Invasive Bladder Neoplasms 01/2022
1	Splenomegaly 12/2021

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 06/2022 - 07/2014
9	Messenger RNA (mRNA)IBA 01/2021 - 07/2008
9	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 03/2007
8	ErbB Receptors (EGF Receptor)IBA 04/2022 - 12/2011
8	Proteins (Proteins, Gene)FDA Link 02/2021 - 12/2002
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 07/2008
5	epidermal growth factor receptor VIIIIBA 04/2022 - 12/2011
5	MicroRNAs (MicroRNA)IBA 05/2020 - 11/2015
5	Bevacizumab (Avastin)FDA Link 01/2019 - 01/2013
5	EnzymesIBA 01/2019 - 03/2007
5	CytokinesIBA 05/2017 - 03/2008
4	B7-H1 AntigenIBA 06/2022 - 01/2020
4	Temozolomide (Temodar)FDA LinkGeneric 01/2019 - 12/2008
4	Biological ProductsIBA 03/2012 - 10/2008
3	AntibodiesIBA 02/2022 - 04/2014
3	Cetuximab (Erbitux)FDA Link 12/2021 - 12/2011
3	Pharmaceutical PreparationsIBA 02/2021 - 01/2015
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 02/2016
3	RNA (Ribonucleic Acid)IBA 01/2021 - 03/2007
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2019 - 01/2013
3	Monoclonal AntibodiesIBA 01/2019 - 10/2017
3	Glutamic Acid (Glutamate)FDA Link 10/2015 - 06/2013
3	Valine (L-Valine)FDA Link 10/2015 - 06/2013
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2007 - 10/2002
2	Formaldehyde (Formol)FDA Link 02/2022 - 01/2019
2	ParaffinIBA 02/2022 - 01/2019
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022 - 01/2002
2	Histones (Histone)IBA 02/2021 - 09/2012
2	Chromogranin AIBA 01/2021 - 07/2016
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2019
2	SynaptophysinIBA 01/2021 - 07/2016
2	Phosphotransferases (Kinase)IBA 01/2021 - 07/2013
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021 - 01/2013
2	Long Noncoding RNAIBA 12/2020 - 05/2020
2	LuciferasesIBA 05/2020 - 03/2012
2	MART-1 AntigenIBA 04/2020 - 07/2016
2	ChromatinIBA 02/2020 - 09/2018
2	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 03/2007
2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 08/2008
2	Anaplastic Lymphoma KinaseIBA 07/2018 - 07/2016
2	Protein Isoforms (Isoforms)IBA 05/2018 - 05/2015
2	Suppressor of Cytokine Signaling 3 ProteinIBA 05/2018 - 05/2017
2	Epidermal Growth Factor (EGF)IBA 11/2017 - 12/2011
2	Galectin 3 (LGALS3)IBA 01/2013 - 12/2012
2	Interleukin-6 (Interleukin 6)IBA 03/2012 - 02/2011
2	Cyclin-Dependent Kinase Inhibitor p16IBA 07/2004 - 12/2002
1	LigandsIBA 01/2022
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2021
1	encorafenibIBA 12/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2021
1	elesclomolIBA 07/2021

Therapy/Procedure

26	Therapeutics 06/2022 - 01/2013
8	Drug Therapy (Chemotherapy) 01/2022 - 12/2011
7	Immunotherapy 06/2022 - 07/2018
7	Radiotherapy 12/2020 - 12/2008
3	Prostatectomy (Retropubic Prostatectomy) 12/2022 - 05/2017
2	Orchiectomy (Orchidectomy) 01/2019 - 01/2019
1	Cytoreduction Surgical Procedures 10/2021
1	Hyperthermic Intraperitoneal Chemotherapy 10/2021